NUVA Share Price

Open 74.34 Change Price %
High 74.88 1 Day 0.25 0.34
Low 74.19 1 Week 0.54 0.73
Close 74.76 1 Month 3.84 5.41
Volume 345036 1 Year 33.42 80.84
52 Week High 75.10
52 Week Low 40.57
NUVA Important Levels
Resistance 2 75.40
Resistance 1 75.14
Pivot 74.61
Support 1 74.38
Support 2 74.12
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

NuVasive, Inc. (NASDAQ: NUVA)

NUVA Technical Analysis 5
As on 24th Feb 2017 NUVA Share Price closed @ 74.76 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 62.01 & Strong Buy for SHORT-TERM with Stoploss of 69.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
NUVA Target for February
1st Target up-side 73.71
2nd Target up-side 75.77
3rd Target up-side 77.83
1st Target down-side 67.83
2nd Target down-side 65.77
3rd Target down-side 63.71
NUVA Other Details
Segment EQ
Market Capital 625492160.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.nuvasive.com
NUVA Address
NUVA
7475 Lusk Boulevard
San Diego, CA 92121
United States
Phone: 858-909-1800
Fax: 800-475-9134
Interactive Technical Analysis Chart NuVasive, Inc. ( NUVA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NuVasive, Inc.
NUVA Business Profile
NuVasive, Inc. is a medical device company, that focuses on developing minimally disruptive surgical products and procedures for the spine. Its marketed product portfolio focused on applications for spine fusion surgery, including biologics. Its principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as offering of biologics, cervical and motion preservation products. spine surgery product line offerings, which include products for the thoracolumbar spine, the cervical spine, and a set of motion preservation product offerings under development, are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologic product line offerings include allograft, FormaGraft, a collagen synthetic product used to aid the fusion process, and Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells (MSCs), to aid in spinal fusion.